JPH11228550A - Isothiocyanate compound - Google Patents
Isothiocyanate compoundInfo
- Publication number
- JPH11228550A JPH11228550A JP3706498A JP3706498A JPH11228550A JP H11228550 A JPH11228550 A JP H11228550A JP 3706498 A JP3706498 A JP 3706498A JP 3706498 A JP3706498 A JP 3706498A JP H11228550 A JPH11228550 A JP H11228550A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- amino acid
- formula
- peptide
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は蛍光標識試薬として
有用な新規なイソチオシアネート化合物に関するもので
ある。The present invention relates to a novel isothiocyanate compound useful as a fluorescent labeling reagent.
【0002】[0002]
【従来の技術】バイオテクノロジーの分野では、ポリペ
プチドやオリゴペプチドなどのペプチド化合物のアミノ
酸配列を迅速に決定することが非常に重要である。ペプ
チド化合物のアミノ酸配列を決定する方法としては、フ
ェニルイソチオシアネート(PITC)を用いるエドマン(Edm
an) 分解法が知られている (Edman, P., Acta Chim. Sc
and., 4, 283, 1950; Edman, P., Acta Chim. Scand.,
10, 761, 1956; Edman,P. and Begg, G., Eur. J. Bioc
hem., 1, 80, 1967) 。エドマン分解法は、ペプチド化
合物のアミノ末端残基のみを標識してフェニルチオヒダ
ントイン誘導体として脱離させ、この誘導体を高速液体
クロマトグラフィー(HPLC) によって分離し、そのアミ
ノ酸の種類を同定する工程を含んでいる。ペプチド化合
物の構成成分であるアミノ酸を順次脱離させて同定する
ことにより、ペプチド化合物の全アミノ酸配列を容易に
決定できるので、エドマン分解法は生化学及びバイオテ
クノロジーの分野で広く用いられている。2. Description of the Related Art In the field of biotechnology, it is very important to rapidly determine the amino acid sequence of peptide compounds such as polypeptides and oligopeptides. As a method for determining the amino acid sequence of a peptide compound, Edman (Edm) using phenylisothiocyanate (PITC) is used.
an) Decomposition method is known (Edman, P., Acta Chim. Sc
and., 4, 283, 1950; Edman, P., Acta Chim. Scand.,
10, 761, 1956; Edman, P. and Begg, G., Eur. J. Bioc
hem., 1, 80, 1967). The Edman degradation method involves labeling only the amino terminal residue of the peptide compound and removing it as a phenylthiohydantoin derivative, separating the derivative by high performance liquid chromatography (HPLC), and identifying the type of the amino acid. In. The Edman degradation method is widely used in the fields of biochemistry and biotechnology because the entire amino acid sequence of a peptide compound can be easily determined by sequentially removing and identifying amino acids that are constituents of the peptide compound.
【0003】近年、エドマン分解法に用いるラベル化剤
として、蛍光標識試薬、例えばフルオレセインイソチオ
シアネート [FITC: Maeda, H. and Kawauchi, H., Bioc
him.Biophys. Res. Commun., 31, 188, 1968]や 4-N,N-
ジメチルアミノ-1- ナフチルイソチオシアネート [DNS
-NCS: Ichikawa, H. and Tanimura, T., Chem. Pharm.
Bull., 18, 1498, 1970] 、N-ダンシルアニリノフェニ
ルイソチオシアナート[DNSA-PITC: Jin, S.-W., et a
l., FEBS Lett., 198, 150, 1986; Hirano, H.and Witt
man-Liebold,, B., Biol. Chem. Hoppe-Seyler, 367, 1
259, 1986]がフェニルイソチオシアネートに代わって用
いられている。また、7-置換-4-(2,1,3-ベンゾオキサジ
アゾリル)イソチオシアネートも優れた蛍光標識試薬と
して開発されている(特公平6-94461 号公報)。In recent years, as a labeling agent used in the Edman degradation method, a fluorescent labeling reagent such as fluorescein isothiocyanate [FITC: Maeda, H. and Kawauchi, H., Bioc.
him.Biophys. Res. Commun., 31, 188, 1968] and 4-N, N-
Dimethylamino-1-naphthylisothiocyanate [DNS
-NCS: Ichikawa, H. and Tanimura, T., Chem. Pharm.
Bull., 18, 1498, 1970], N-dansylanilinophenyl isothiocyanate [DNSA-PITC: Jin, S.-W., et a
l., FEBS Lett., 198, 150, 1986; Hirano, H. and Witt
man-Liebold ,, B., Biol. Chem. Hoppe-Seyler, 367, 1
259, 1986] have been used in place of phenylisothiocyanate. Also, 7-substituted-4- (2,1,3-benzoxdiadialyl) isothiocyanate has been developed as an excellent fluorescent labeling reagent (Japanese Patent Publication No. 6-94461).
【0004】これらの蛍光標識試薬を用いることによっ
て、誘導体化されたアミノ酸の検出感度が大きく向上し
たため、微量のペプチド化合物のアミノ酸配列も決定で
きるようになっている。もっとも、最近ではD-アミノ酸
を含む新たなペプチド化合物が種々発見されており、そ
の重要性が解明されるにつれて、アミノ酸がD-アミノ酸
であるかL-アミノ酸であるかを決定できる配列決定法が
必要になってきた。従来の蛍光性色素はそれ自体の分子
構造が非常に大きいため、標識化された光学活性アミノ
酸の間のわずかな構造上の違いを HPLC 法では判別でき
ないという問題がある。従って、微量のペプチド化合物
を構成するアミノ酸の種類とコンフィギュレーション
(D-体又はL-体)を判別できる標識試薬の開発が望まれ
ている。[0004] By using these fluorescent labeling reagents, the detection sensitivity of derivatized amino acids has been greatly improved, so that the amino acid sequence of a trace amount of a peptide compound can be determined. However, recently, various new peptide compounds containing D-amino acids have been discovered, and as their importance has been elucidated, a sequencing method capable of determining whether an amino acid is a D-amino acid or an L-amino acid has been developed. It has become necessary. Since the conventional fluorescent dye has a very large molecular structure itself, there is a problem that a slight structural difference between labeled optically active amino acids cannot be distinguished by the HPLC method. Therefore, development of a labeling reagent capable of discriminating the type and configuration (D-form or L-form) of amino acids constituting a trace amount of a peptide compound is desired.
【0005】[0005]
【発明が解決しようとする課題】本発明の課題は蛍光標
識試薬として有用な化合物を提供することにある。より
具体的には、微量のペプチド化合物を構成するアミノ酸
の種類とコンフィギュレーションを正確に判別できる標
識試薬として有用なイソチオシアネート化合物を提供す
ることが本発明の課題である。本発明の別の課題は、上
記の特徴を有する標識試薬を提供することにある。An object of the present invention is to provide a compound useful as a fluorescent labeling reagent. More specifically, it is an object of the present invention to provide an isothiocyanate compound that is useful as a labeling reagent that can accurately determine the type and configuration of amino acids constituting a trace amount of a peptide compound. Another object of the present invention is to provide a labeling reagent having the above characteristics.
【0006】[0006]
【課題を解決するための手段】本発明者は上記の課題を
解決すべく鋭意研究を重ねた結果、下記のイソチオシア
ネート化合物がペプチド化合物のアミノ酸配列を決定す
るための蛍光標識試薬として極めて有用であり、特にア
ミノ酸のコンフィギュレーションを正確に判定するため
の高感度な蛍光標識試薬として有用であることを見出し
た。本発明はこれらの知見を基にして完成されたもので
ある。The present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, the following isothiocyanate compounds are extremely useful as fluorescent labeling reagents for determining the amino acid sequence of peptide compounds. In particular, they have found that they are useful as highly sensitive fluorescent labeling reagents for accurately determining the configuration of amino acids. The present invention has been completed based on these findings.
【0007】すなわち本発明は、式(I):That is, the present invention provides a compound represented by the formula (I):
【化2】 (式中、Rは置換基を有することもあるフェニル基を示
す)で表わされる化合物を提供するものである。この発
明の好ましい態様によれば、Rが無置換フェニル基であ
る上記化合物が提供される。Embedded image (Wherein R represents a phenyl group which may have a substituent). According to a preferred embodiment of the present invention, there is provided the above compound, wherein R is an unsubstituted phenyl group.
【0008】別の観点からは、本発明により、上記の式
(I) で表される化合物を含む蛍光標識試薬が提供され
る。この蛍光標識試薬はペプチド化合物のアミノ酸配列
分析や、アミン化合物、アミノ酸化合物、又はペプチド
化合物の蛍光定量分析などに用いることができ、好まし
くはペプチド化合物を構成するアミノ酸のコンフィギュ
レーション決定に用いることができる。さらに別の観点
からは、式(I) の化合物で蛍光標識化されたアミノ酸化
合物が提供される。この化合物は、ペプチド化合物のア
ミノ酸配列において高速液体クロマトグラフィーなどの
分析を行う場合の標準物質として用いることができる。[0008] In another aspect, the present invention provides,
A fluorescent labeling reagent comprising the compound represented by (I) is provided. This fluorescent labeling reagent can be used for the amino acid sequence analysis of a peptide compound, the fluorescence quantitative analysis of an amine compound, an amino acid compound, or a peptide compound, and can be preferably used for determining the configuration of the amino acid constituting the peptide compound. . In yet another aspect, there is provided an amino acid compound fluorescently labeled with a compound of formula (I). This compound can be used as a standard substance when performing an analysis such as high performance liquid chromatography on the amino acid sequence of the peptide compound.
【0009】[0009]
【発明の実施の形態】上記の式(I) において、Rは置換
基を有することもあるフェニル基を示す。フェニル基上
の置換基の個数は特に限定されないが、例えば、1から
3個、好ましくは1又は2個程度である。複数の置換基
が存在する場合には、それらは同一でも異なっていても
よい。また、フェニル基上の置換基の位置は特に限定さ
れず、任意の位置に置換することが可能である。BEST MODE FOR CARRYING OUT THE INVENTION In the above formula (I), R represents a phenyl group which may have a substituent. The number of substituents on the phenyl group is not particularly limited, but is, for example, about 1 to 3, preferably about 1 or 2. When a plurality of substituents are present, they may be the same or different. In addition, the position of the substituent on the phenyl group is not particularly limited, and it is possible to substitute at an arbitrary position.
【0010】例えば、フェニル基上の置換基として、C
1-4アルキル基(メチル基、エチル基など)、C1-4アル
コキシ基(メトキシ基、エトキシ基など)、カルボキシ
ル基、ハロゲン原子(フッ素原子、塩素原子、臭素原子
など)、C1-4アルキルカルボニル基(アセチル基な
ど)、C1-4アルコキシカルボニル基(エトキシカルボニ
ル基など)、アミノ基、モノ若しくはジ置換アミノ基
(モノ若しくはジC1-4アルキル基アミノ基など)、ニト
ロ基、及びシアノ基からなる群から選ばれる1又は2個
以上の置換基を用いることができる。For example, as a substituent on a phenyl group, C
1-4 alkyl group (methyl group, ethyl group, etc.), C 1-4 alkoxy group (methoxy group, ethoxy group, etc.), carboxyl group, halogen atom (fluorine atom, chlorine atom, bromine atom, etc.), C 1-4 An alkylcarbonyl group (such as an acetyl group), a C 1-4 alkoxycarbonyl group (such as an ethoxycarbonyl group), an amino group, a mono- or di-substituted amino group (such as a mono- or di-C 1-4 alkyl-amino group), a nitro group, And one or more substituents selected from the group consisting of cyano groups.
【0011】本発明の化合物は、例えば塩酸塩などの塩
を形成することがあるが、塩の形態の化合物も本発明の
範囲に包含されることはいうまでもない。また、任意の
水和物又は溶媒和物も本発明の範囲に包含される。本発
明の化合物の製造方法は、本明細書の実施例に具体的か
つ詳細に説明されているので、当業者は、それらの説明
を参照しつつ、原料化合物、反応条件、及び試薬などを
適宜修飾ないし改変することにより、上記一般式に包含
される本発明の化合物を容易に製造することが可能であ
る。Rが置換基を有するフェニル基である化合物は、対
応する置換基を有するチオフェノール誘導体を出発原料
として用いることにより、容易に製造することができ
る。反応を行うにあたり、必要に応じて置換基を適宜の
保護基で保護しておいてもよい。The compound of the present invention may form a salt such as a hydrochloride, but it goes without saying that the compound in the form of a salt is also included in the scope of the present invention. Also, any hydrate or solvate is included in the scope of the present invention. Since the method for producing the compound of the present invention is specifically and specifically described in the Examples of the present specification, those skilled in the art can appropriately refer to the descriptions and use the starting materials, reaction conditions, reagents, and the like as appropriate. The compound of the present invention included in the above general formula can be easily produced by modification or alteration. A compound in which R is a phenyl group having a substituent can be easily produced by using a thiophenol derivative having a corresponding substituent as a starting material. In carrying out the reaction, the substituent may be protected with an appropriate protecting group, if necessary.
【0012】式(I) で表される本発明の化合物は、ペプ
チド化合物の末端アミノ酸と温和な条件で効率的に反応
することができ、反応後のペプチド化合物を三フッ化ホ
ウ素やトリフルオロ酢酸で処理することにより、、ペプ
チド鎖から2,1,3-ベンゾオキサジアゾール誘導体で標識
された蛍光性のアミノ酸誘導体(チオカルバミルアミノ
酸)を切断することができる。この標識化アミノ酸は、
例えば高速液体クロマトグラフィーなどの手段により容
易に分離することができ、その光学異性体を同定するこ
とも可能である。その具体的方法は、例えば、特願平9-
269617号明細書の実施例に詳細に説明されている。The compound of the present invention represented by the formula (I) can efficiently react with the terminal amino acid of the peptide compound under mild conditions, and after the reaction, the peptide compound can be reacted with boron trifluoride or trifluoroacetic acid. , A fluorescent amino acid derivative (thiocarbamyl amino acid) labeled with a 2,1,3-benzoxadiazole derivative can be cleaved from the peptide chain. This labeled amino acid is
For example, it can be easily separated by means such as high performance liquid chromatography, and its optical isomer can be identified. The specific method is, for example,
This is described in detail in the examples of 269617.
【0013】従って、本発明の化合物は、ペプチド化合
物のアミノ酸配列分析用の蛍光標識試薬として有用であ
る。上記の分析方法の操作自体は、蛍光標識試薬を用い
たエドマン法として当業界で汎用されており、当業者は
従来の蛍光標識試薬に代えて本発明の化合物を蛍光標識
試薬として用いることにより、極めて高感度な分析を容
易に行うことが可能である。なお、本明細書において用
いられる「ペプチド化合物」という用語は、蛋白質(ポ
リペプチド)、アミノ酸残基数が10個程度以下のオリゴ
ペプチドなどを含めて、ペプチド結合した2個以上のア
ミノ酸残基を含む化合物を包含する概念として用いてお
り、最も広義に解釈すべきである。Accordingly, the compounds of the present invention are useful as fluorescent labeling reagents for analyzing amino acid sequences of peptide compounds. The operation itself of the above analysis method is widely used in the art as the Edman method using a fluorescent labeling reagent, and those skilled in the art can use the compound of the present invention as a fluorescent labeling reagent instead of a conventional fluorescent labeling reagent. Extremely sensitive analysis can be easily performed. As used herein, the term “peptide compound” refers to two or more peptide-bonded amino acid residues, including proteins (polypeptides) and oligopeptides having about 10 amino acid residues or less. It is used as a concept that encompasses compounds that include and should be interpreted in the broadest sense.
【0014】また、式(I) で表される本発明の化合物を
含む蛍光標識試薬は、ナノモルないしピコモルレベルの
アミン、アミノ酸、ペプチド化合物の蛍光定量分析に用
いることも可能である。さらに、組織切片や体液などの
生体組織試料を対象とした生体外での顕微鏡下によるア
ミン化合物、アミノ酸化合物、若しくはペプチド化合物
の検出;又はアミン化合物、アミノ酸化合物、若しくは
ペプチド化合物の検出を目的として生体内で内視鏡など
を用いて行われる生体組織の染色などに用いることもで
きる。The fluorescent labeling reagent containing the compound of the present invention represented by the formula (I) can also be used for the quantitative analysis of amine, amino acid and peptide compounds at the nanomolar or picomolar level. In addition, detection of amine compounds, amino acid compounds, or peptide compounds under a microscope in vitro on biological tissue samples such as tissue sections or body fluids; or production of amine compounds, amino acid compounds, or peptide compounds for the purpose of detection. It can also be used for staining living tissue performed in vivo using an endoscope or the like.
【0015】本発明の蛍光標識試薬はイソチオシアナー
トの反応性が高いのでペプチド末端のアミノ酸と極めて
容易に反応することができるうえ、蛍光基がコンパクト
であることから、アミノ酸のD/L 光学異性体を高速液体
クロマトグラフィーで分離できるという特徴がある。ま
た、蛍光基の励起及び発光波長がノイズの影響を受けに
くい長波長域であり、蛍光強度に優れ安定性の高い蛍光
性誘導体を与えるという特徴がある。Since the fluorescent labeling reagent of the present invention has high reactivity with isothiocyanate, it can react with the amino acid at the terminal of the peptide very easily. In addition, since the fluorescent group is compact, the D / L optical isomer The feature is that the body can be separated by high performance liquid chromatography. In addition, the excitation and emission wavelength of the fluorescent group is a long wavelength range that is hardly affected by noise, and a fluorescent derivative having excellent fluorescence intensity and high stability is provided.
【0016】[0016]
【実施例】以下、本発明を実施例によりさらに具体的に
説明するが、本発明の範囲は下記の実施例に限定される
ことはない。なお、実施例中の化合物番号は下記のスキ
ーム中の化合物番号に対応させてある。EXAMPLES Hereinafter, the present invention will be described more specifically with reference to Examples, but the scope of the present invention is not limited to the following Examples. The compound numbers in the examples correspond to the compound numbers in the following scheme.
【化3】 Embedded image
【0017】例1 (3) の合成 1.0 g の (2) (NBD-Cl) をアセトニトリル 10 mlに溶解
し、チオフェノール 1.0 ml を加え攪拌しつつ、トリエ
チルアミン 0.8 ml を滴下し、室温で2時間攪拌した。
反応液を減圧濃縮し、生成する沈殿をろ取し黄色結晶
1.2 gを得た。APCl-MS ; M- = 273 (4) の合成 500 mgの (3)をメタノール 20 mlおよび塩化メチレン 1
0 mlに溶解し、濃塩酸2.5 ml を加えた。この溶液に鉄
粉 350 ml を加え、室温で激しく攪拌し、さらに鉄粉を
少量加えて 30 分攪拌後、反応液をろ過し鉄粉を除去し
た。シリカゲルカラム(塩化メチレン:ヘキサン=2:
1で溶出)で精製し 170 mg の黄色結晶を得た。Example 1 Synthesis of (3) 1.0 g of (2) (NBD-Cl) was dissolved in 10 ml of acetonitrile, 1.0 ml of thiophenol was added, and 0.8 ml of triethylamine was added dropwise with stirring, followed by 2 hours at room temperature. Stirred.
The reaction solution was concentrated under reduced pressure, and the resulting precipitate was collected by filtration and yellow crystals
1.2 g were obtained. APCl-MS; M - = 273 (4) Synthesis 500 mg of (3) 20 ml of methanol and methylene chloride 1
The solution was dissolved in 0 ml, and 2.5 ml of concentrated hydrochloric acid was added. To this solution was added 350 ml of iron powder, and the mixture was vigorously stirred at room temperature. Further, a small amount of iron powder was added, and the mixture was stirred for 30 minutes. Then, the reaction solution was filtered to remove iron powder. Silica gel column (methylene chloride: hexane = 2:
And eluted with 1) to give 170 mg of yellow crystals.
【0018】(5) の合成 300 mgの (4)を塩化メチレンに溶解し、3等量の m-CPB
A を加え、室温で攪拌した。原料が消失するまでさらに
m-CPBA を追加し、室温で攪拌し、反応液を飽和 NaHCO
3 溶液で洗浄、Na2SO4で乾燥後、溜去した。シリカゲル
カラム(塩化メチレンで溶出)で精製し、黄色結晶 150
mg を得た。APCl-MS ; (M+H) + = 276,(M-H)- = 274 (1) の合成 150 mgの (5)をアセトニトリル 15 mlに溶解し CSCl2
0.3 ml をベンゼン 1.0ml に溶解した溶液を加え、5 時
間加熱還流した。反応終了後、反応液を減圧溜去した。
シリカゲルカラム(ヘキサン:酢酸エチル=3:1)で
精製し黄色結晶60 mgを得た。APCl-MS ; (M+H)+ = 31
8, M- = 317Synthesis of (5) 300 mg of (4) is dissolved in methylene chloride and 3 equivalents of m-CPB
A was added and stirred at room temperature. Until the ingredients disappear
Add m-CPBA, stir at room temperature, and wash the reaction with saturated NaHCO
After washing with three solutions, drying with Na 2 SO 4 and distilling off. Purify on silica gel column (eluted with methylene chloride) to obtain yellow crystals.
mg was obtained. APCl-MS; Synthesis of (M + H) + = 276, (MH) - = 274 (1) Dissolve 150 mg of (5) in 15 ml of acetonitrile and add CSCl 2
A solution in which 0.3 ml of benzene was dissolved in 1.0 ml of benzene was added, and the mixture was refluxed for 5 hours. After completion of the reaction, the reaction solution was distilled off under reduced pressure.
Purification by a silica gel column (hexane: ethyl acetate = 3: 1) gave 60 mg of yellow crystals. APCl-MS; (M + H) + = 31
8, M - = 317
【0019】[0019]
【発明の効果】本発明の化合物はそれ自体では蛍光を示
さず、アミン化合物、アミノ酸化合物、ペプチド化合物
などのアミノ基と選択的に反応結合した後、顕著な蛍光
を発する性質を有している。従って、本発明の化合物
は、これらの化合物の蛍光分析やペプチド化合物のアミ
ノ酸配列決定用の蛍光標識試薬として用いることができ
る。特に、本発明の化合物は光学活性アミノ酸を分離す
ることができるので、D-アミノ酸を含むペプチド化合物
のアミノ酸配列決定に有用である。The compound of the present invention does not exhibit fluorescence by itself, and has the property of emitting remarkable fluorescence after selectively reacting and bonding with amino groups of amine compounds, amino acid compounds, peptide compounds and the like. . Therefore, the compounds of the present invention can be used as fluorescent labeling reagents for the fluorescence analysis of these compounds and the amino acid sequencing of peptide compounds. In particular, since the compound of the present invention can separate optically active amino acids, it is useful for determining the amino acid sequence of peptide compounds containing D-amino acids.
Claims (7)
す)で表わされる化合物。(1) Formula (I): (Wherein, R represents a phenyl group which may have a substituent).
記載の化合物。2. The compound according to claim 1, wherein R is an unsubstituted phenyl group.
光標識試薬。3. A fluorescent labeling reagent comprising the compound according to claim 1 or 2.
いる請求項3に記載の蛍光標識試薬。4. The fluorescent labeling reagent according to claim 3, which is used for amino acid sequence analysis of a peptide compound.
のコンフィギュレーション決定に用いる請求項3又は4
に記載の試薬。5. The method according to claim 3, which is used for determining the configuration of amino acid residues constituting the peptide compound.
The reagent according to 1.
プチド化合物の蛍光定量分析に用いる請求項3に記載の
試薬。6. The reagent according to claim 3, which is used for a fluorimetric analysis of an amine compound, an amino acid compound, or a peptide compound.
標識化されたアミノ酸化合物。7. An amino acid compound fluorescently labeled with the compound of the formula (I) according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3706498A JPH11228550A (en) | 1998-02-19 | 1998-02-19 | Isothiocyanate compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3706498A JPH11228550A (en) | 1998-02-19 | 1998-02-19 | Isothiocyanate compound |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11228550A true JPH11228550A (en) | 1999-08-24 |
Family
ID=12487134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3706498A Pending JPH11228550A (en) | 1998-02-19 | 1998-02-19 | Isothiocyanate compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH11228550A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004087684A1 (en) * | 2003-04-04 | 2004-10-14 | Novartis Ag | Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers |
-
1998
- 1998-02-19 JP JP3706498A patent/JPH11228550A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004087684A1 (en) * | 2003-04-04 | 2004-10-14 | Novartis Ag | Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers |
JP2006521290A (en) * | 2003-04-04 | 2006-09-21 | ノバルティス アクチエンゲゼルシャフト | Benzo [1,2,5] oxadiazole and benzo [1,2,5] thiadiazole useful as histopathological stains, contrast agents and biomarkers |
CN100402512C (en) * | 2003-04-04 | 2008-07-16 | 诺瓦提斯公司 | Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers. |
US7632851B2 (en) | 2003-04-04 | 2009-12-15 | Novartis Ag | Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10545153B2 (en) | Single molecule peptide sequencing | |
JP2678597B2 (en) | Method for electrophoretically detecting separated oligonucleotides | |
Holmes | Model studies for new o-nitrobenzyl photolabile linkers: Substituent effects on the rates of photochemical cleavage | |
JP3119171B2 (en) | Oligonucleotide-polyamide conjugate | |
JP5924939B2 (en) | Novel fluorescent boron-substituted dipyrromethene and its use in diagnosis | |
JP5638734B2 (en) | Labeling dye for biomolecule, labeling kit, and method for detecting biomolecule | |
US9933431B2 (en) | System and method for iterative detection of biological molecules | |
US20230107647A1 (en) | Single molecule peptide sequencing | |
US7897787B2 (en) | Maleimide derivative | |
JP4801445B2 (en) | Biomolecule detection method and labeling dye and labeling kit used therefor | |
US4237047A (en) | Peptide derivative | |
JP4392502B2 (en) | Fluorescent amino acid derivatives | |
JP2005208026A (en) | Biomolecule detecting method, labeling coloring matter used therein and labeling kit | |
US20140051109A1 (en) | Novel compounds with photoluminescence properties and applications thereof | |
CN104910894B (en) | Benzimidazole hERG potassium ion channel small-molecular fluorescent probe and preparation method and applications thereof | |
US4861726A (en) | Method of thioacylation peptide sequencing with acylation of thiazoloinones | |
JP7339675B2 (en) | Fluorescent probe for detecting carboxypeptidase activity | |
JPH11228550A (en) | Isothiocyanate compound | |
Cserép et al. | Fluorogenic tagging of peptides via Cys residues using thiol-specific vinyl sulfone affinity tags | |
US20080269065A1 (en) | Conformationally Constrained Analytical Probes | |
JP2001136974A (en) | Method for screening out physiologically active pyrrole imidazole derivative | |
CN108586448A (en) | A kind of quinoline salt type compound and its application | |
JPH11106379A (en) | Isothiocyanate compound | |
JPH08271430A (en) | Novel fluorescent dye | |
US20070161807A1 (en) | Method for manufacturing optically pure coumaryl amino acids and the novel coumaryl aminoacids thus obtained |